"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Gland Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations	Chairman : SRINIVAS SADU
Home : MNC Associate	Book Value: 610.0166926
BSE Code : 543245	Market Cap: 30761.67
NSE Code : GLAND	P / E : 25.92

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	1261.59	1177.51	1074.15	1038.84
Other Income	106.36	60.21	82.59	54.74
Total Income	1367.95	1237.72	1156.74	1093.58
Total Expenditure	753.88	780.23	699.27	679.99
Operating Profit	614.07	457.49	457.48	413.59
Interest	6.17	0.50	3.97	7.44
Gross Profit	607.91	456.99	453.51	406.15
Depreciation	43.11	44.53	44.84	43.77
Tax	143.21	110.21	105.90	93.27
Deferred Tax	1.13	-5.60	0.78	-0.15
Reported Profit After Tax	420.45	307.85	302.00	269.26

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView